Weight-loss drugs are a golden ticket for health-linked stocks
New drugs that slim down patients are boosting the stocks of companies that may benefit from the next chapter in weight loss.
By Carmen Reinicke, bloomberg
The medicines known as glucagon-like peptide agonists, or GLP-1s, are making waves with celebrity influencers as well as investors, sending shares of Eli Lilly & Co. and Novo Nordisk A/S soaring. WW International Inc., better known as WeightWatchers, also surged after a deal that would help people gain access to the drugs.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
.jpg)
